tiprankstipranks
Viking Therapeutics (DE:1VT)
FRANKFURT:1VT

Compare Viking Therapeutics (1VT) vs. Competitors

75 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Viking Therapeutics
€28.80
€3.49B
-6.36
28.72%
12 Buy
0 Hold
0 Sell
Strong Buy
Ultragenyx Pharmaceutical
$22.45
$2.17B
-3.94
-36.53%
17 Buy
2 Hold
0 Sell
Strong Buy
Xenon
$56.85
$5.43B
-10.27
80.71%
19 Buy
0 Hold
0 Sell
Strong Buy
Scholar Rock Holding
$50.01
$5.75B
-13.37
53.69%
14 Buy
0 Hold
0 Sell
Strong Buy
Immunovant
$24.50
$4.99B
-10.43
49.21%
9 Buy
2 Hold
0 Sell
Strong Buy
NewAmsterdam Pharma Company
$32.99
$3.79B
-19.69
81.16%
11 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:1VT
Viking Therapeutics
28.80
9.41
48.57%
RARE
Ultragenyx Pharmaceutical
22.45
-9.69
-30.15%
XENE
Xenon
56.85
26.22
85.60%
SRRK
Scholar Rock Holding
50.01
23.97
92.05%
IMVT
Immunovant
24.50
10.11
70.26%
NAMS
NewAmsterdam Pharma Company
32.99
17.13
108.01%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts